ZA200807063B - Isolated organ perfusion combination therapy of cancer - Google Patents

Isolated organ perfusion combination therapy of cancer

Info

Publication number
ZA200807063B
ZA200807063B ZA200807063A ZA200807063A ZA200807063B ZA 200807063 B ZA200807063 B ZA 200807063B ZA 200807063 A ZA200807063 A ZA 200807063A ZA 200807063 A ZA200807063 A ZA 200807063A ZA 200807063 B ZA200807063 B ZA 200807063B
Authority
ZA
South Africa
Prior art keywords
cancer
combination therapy
organ perfusion
isolated organ
perfusion combination
Prior art date
Application number
ZA200807063A
Other languages
English (en)
Inventor
Goodman Simon
Grell Matthias
Hagen Timo L M Ten
Alexander M M Eggermont
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA200807063B publication Critical patent/ZA200807063B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA200807063A 2006-01-18 2008-08-15 Isolated organ perfusion combination therapy of cancer ZA200807063B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06001049 2006-01-18

Publications (1)

Publication Number Publication Date
ZA200807063B true ZA200807063B (en) 2009-10-28

Family

ID=37824910

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200807063A ZA200807063B (en) 2006-01-18 2008-08-15 Isolated organ perfusion combination therapy of cancer

Country Status (11)

Country Link
US (1) US20110165150A1 (fr)
EP (1) EP1978991A1 (fr)
JP (1) JP2009525957A (fr)
KR (1) KR20080089645A (fr)
CN (1) CN101370512A (fr)
AU (1) AU2007207074B8 (fr)
BR (1) BRPI0706541A2 (fr)
CA (1) CA2637540A1 (fr)
EA (1) EA200801670A1 (fr)
WO (1) WO2007082742A1 (fr)
ZA (1) ZA200807063B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102481798B1 (ko) 2006-06-09 2022-12-26 애플 인크. 터치 스크린 액정 디스플레이
RU2664631C1 (ru) * 2017-05-25 2018-08-21 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Способ изолированной гипертермической химиоперфузии печени
RU2747908C1 (ru) * 2020-03-05 2021-05-17 Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) Способ изолированной долевой порто-кавальной перфузии печени в эксперименте
RU2740570C1 (ru) * 2020-03-05 2021-01-15 Федеральное государственное бюджетное военное образовательное учреждение высшего образования "Военно-медицинская академия имени С.М. Кирова" Министерства обороны Российской Федерации (ВМедА) Способ изолированной долевой ретроградной перфузии печени в эксперименте

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19842415A1 (de) * 1998-09-16 2000-03-23 Merck Patent Gmbh Pharmazeutische Zubereitung
CA2436326C (fr) * 2001-01-09 2012-08-14 Merck Patent Gesellschaft Mit Beschraenkter Haftung Polytherapie faisant appel a des inhibiteurs de recepteurs tyrosine kinase et a des inhibiteurs d'angiogenese
US20040136949A1 (en) * 2001-04-24 2004-07-15 Matthias Grell Combination therapy using anti-angiogenic agents and tnf alpha
JP2005533001A (ja) * 2002-03-04 2005-11-04 メディミューン，インコーポレーテッド インテグリンαｖβ３アンタゴニストを他の物質と併用投与する癌の予防または治療方法
JP5179702B2 (ja) * 2002-10-10 2013-04-10 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 受容体Ｅｒｂ−Ｂ１に対する医薬組成物

Also Published As

Publication number Publication date
EP1978991A1 (fr) 2008-10-15
WO2007082742A1 (fr) 2007-07-26
EA200801670A1 (ru) 2009-02-27
KR20080089645A (ko) 2008-10-07
US20110165150A1 (en) 2011-07-07
AU2007207074B2 (en) 2013-01-17
CA2637540A1 (fr) 2007-07-26
AU2007207074A1 (en) 2007-07-26
CN101370512A (zh) 2009-02-18
WO2007082742A8 (fr) 2008-05-15
AU2007207074B8 (en) 2013-01-31
JP2009525957A (ja) 2009-07-16
BRPI0706541A2 (pt) 2011-03-29

Similar Documents

Publication Publication Date Title
IL248204A0 (en) Combined treatment of tumors expressing 38cd
IL197315A0 (en) Treatment of cancer
EP2056808A4 (fr) Potentialisateur de petite molécule utilisé en hormonothérapie pour le cancer du sein
ZA200800907B (en) Treatment of cancer
ZA201004403B (en) Therapeutic cancer treatments
EP1962839A4 (fr) Administration d'un inhibiteur de mntor pour le traitement des patients atteints du cancer
IL179401A0 (en) Therapy of platinum-resistant cancer
EP2049139A4 (fr) Traitement de tumeurs exprimant ras
EP2068864A4 (fr) Utilisations thérapeutiques d'urolithines
IL188430A0 (en) Treatment of tumors
SI1858929T1 (sl) Diagnoza raka prostate
EP2155231A4 (fr) Imagerie et thérapie des tumeurs associées à un virus
EP1989216A4 (fr) Diagnostic et traitement du cancer de la prostate
IL200525A0 (en) Methods of treating cancer by administering human il-18 combinations
HK1130481A1 (en) Potentiator of radiation therapy
EP2029156A4 (fr) Polythérapie pour traiter le cancer
EP2195425A4 (fr) Pkib et naaladl2 pour des gènes cibles d'une thérapie et d'un diagnostic du cancer de la prostate
ZA200807063B (en) Isolated organ perfusion combination therapy of cancer
GB0520067D0 (en) Treatment of cancer
EP2099303A4 (fr) Compositions à base de tétrahydroisoquinoléine thérapeutiques pour le traitement du cancer
ZA201001876B (en) Treatment of lung cancer
GB0600903D0 (en) Treatment of cancer
ZA200905693B (en) Methods of treating cancer by administering human IL-18 combinations
GB0622581D0 (en) Treatment of cancer
GB0606702D0 (en) Cancer therapeutic